Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma

Multiple myeloma (MM) is a highly refractory hematologic cancer. Targeted immunotherapy has shown promise in MM but remains hindered by the challenge of identifying specific yet broadly representative tumor markers. We analyzed 53 bone marrow (BM) aspirates from 41 MM patients using an unbiased, hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Lijun, Wang, Julia T., Jayasinghe, Reyka G., O'Neal, Julie, Tsai, Chia-Feng, Rettig, Michael P., Song, Yizhe, Liu, Ruiyang, Zhao, Yanyan, Ibrahim, Omar M., Fiala, Mark A., Fortier, Julie M., Chen, Siqi, Gehrs, Leah, Rodrigues, Fernanda Martins, Wendl, Michael C., Kohnen, Daniel, Shinkle, Andrew, Cao, Song, Foltz, Steven M., Zhou, Daniel Cui, Storrs, Erik, Wyczalkowski, Matthew A., Mani, Smrithi, Goldsmith, Scott R., Zhu, Ying, Hamilton, Mark, Liu, Tao, Chen, Feng, Vij, Ravi, Ding, Li, DiPersio, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Genome and Epigenome
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102848/
https://www.ncbi.nlm.nih.gov/pubmed/36779841
http://dx.doi.org/10.1158/0008-5472.CAN-22-1769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102848/
https://www.ncbi.nlm.nih.gov/pubmed/36779841
http://dx.doi.org/10.1158/0008-5472.CAN-22-1769

Ejemplares similares